Human EGFR (Research Grade Matuzumab Biosimilar) Antibody New
Human EGFR (Research Grade Matuzumab Biosimilar) Antibody Summary
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Detection of EGF R in A431 human epithelial carcinoma cell line by Flow Cytometry. A431 human epithelial carcinoma cell line was stained with Human Anti-Human EGF R (Research Grade Matuzumab Biosimilar) Monoclonal Antibody (Catalog # MAB10023, filled histogram) or irrelevant antibody (open histogram) followed by APC-conjugated Anti-Human IgG Secondary Antibody (Catalog # F0135). View our protocol for Staining Membrane-associated Proteins.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Matuzumab is a biosimilar directed against the extracellular domain of EGFR. Matuzumab binds to epidermal growth factor receptor (EGFR) on the outer membrane of normal and tumor cells. The matuzumab epitope has been mapped to domain III of the extracellular domain of the EGFR.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human EGFR (Research Grade Matuzumab Biosimilar) Antibody
There are currently no reviews for this product. Be the first to review Human EGFR (Research Grade Matuzumab Biosimilar) Antibody and earn rewards!
Have you used Human EGFR (Research Grade Matuzumab Biosimilar) Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image